Analysis of the chemical components of Qixianqingming granules and their metabolites in rats by UPLC-ESI-Q-TOF-MS.
Autor: | Zhang B; State Key Laboratory of New Drug and Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai, China., Li MY; State Key Laboratory of New Drug and Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai, China., Luo XM; Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Wang XB; Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Wu T; State Key Laboratory of New Drug and Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of mass spectrometry : JMS [J Mass Spectrom] 2020 Jan; Vol. 55 (1), pp. e4484. Date of Electronic Publication: 2019 Dec 11. |
DOI: | 10.1002/jms.4484 |
Abstrakt: | Qixianqingming granules (QXQM) comprise a traditional Chinese medicine (TCM) formula that was developed based on the combination of TCM theory and clinical practice. This formula has been proven to effectively treat asthma. In this study, an analytical procedure using ultraperformance liquid chromatography, coupled with electrospray ionization quadrupole time-of-flight mass spectrometry, was established for the rapid separation and sensitive identification of the chemical components in QXQM and its metabolites in serum of rats. Seventy-two compounds were systematically identified in QXQM, including flavonoids, terpenoids, anthraquinones, phenylethanoid glycosides, stilbenes, alkaloids, and organic acids. Thirteen prototype compounds and 29 metabolites were detected in the serum of rats. The results provided fundamental information for further studying the mechanisms and clinical application of QXQM. (© 2019 John Wiley & Sons, Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |